Skip to content
10-K

Annual Report

Beam Therapeutics Inc. BEAM

0001193125-26-065194

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 17, 2026 101.86M sh
Shares Diluted FY 2025 · Dec 31, 2025 98.91M sh
Shares Diluted FY 2025 · Dec 31, 2024 82.31M sh
Shares Diluted FY 2025 · Dec 31, 2023 77.15M sh
Capex FY 2025 · Dec 31, 2025 $14.95M
Capex FY 2025 · Dec 31, 2024 $8.95M
Capex FY 2025 · Dec 31, 2023 $33.73M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$345.1M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$347.25M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$149.2M
Cash And Equivalents FY 2025 · Dec 31, 2025 $294.94M
Cash And Equivalents FY 2025 · Dec 31, 2024 $281.97M
Cash And Equivalents FY 2025 · Dec 31, 2023 $435.9M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.24B
Stockholders Equity FY 2025 · Dec 31, 2024 $733.55M
Stockholders Equity FY 2025 · Dec 31, 2023 $981.33M
Stockholders Equity FY 2025 · Dec 31, 2022 $733.47M
Current Liabilities FY 2025 · Dec 31, 2025 $96.94M
Current Liabilities FY 2025 · Dec 31, 2024 $182.07M
Total Liabilities FY 2025 · Dec 31, 2025 $242.82M
Total Liabilities FY 2025 · Dec 31, 2024 $370.28M
Current Assets FY 2025 · Dec 31, 2025 $1.27B
Current Assets FY 2025 · Dec 31, 2024 $878.15M
Total Assets FY 2025 · Dec 31, 2025 $1.48B
Total Assets FY 2025 · Dec 31, 2024 $1.1B
Eps Diluted FY 2025 · Dec 31, 2025 −$0.81
Eps Diluted FY 2025 · Dec 31, 2024 −$4.58
Eps Diluted FY 2025 · Dec 31, 2023 −$1.72
Eps Basic FY 2025 · Dec 31, 2025 −$0.81
Eps Basic FY 2025 · Dec 31, 2024 −$4.58
Eps Basic FY 2025 · Dec 31, 2023 −$1.72
Sga Expense FY 2025 · Dec 31, 2025 $113.82M
Sga Expense FY 2025 · Dec 31, 2024 $111.53M
Sga Expense FY 2025 · Dec 31, 2023 $116.81M
Rd Expense FY 2025 · Dec 31, 2025 $409.62M
Rd Expense FY 2025 · Dec 31, 2024 $367.56M
Rd Expense FY 2025 · Dec 31, 2023 $437.38M
Net Income FY 2025 · Dec 31, 2025 −$79.99M
Net Income FY 2025 · Dec 31, 2024 −$376.74M
Net Income FY 2025 · Dec 31, 2023 −$132.53M
Operating Income FY 2025 · Dec 31, 2025 −$383.69M
Operating Income FY 2025 · Dec 31, 2024 −$415.57M
Operating Income FY 2025 · Dec 31, 2023 −$176.49M
Revenue FY 2025 · Dec 31, 2025 $139.74M
Revenue FY 2025 · Dec 31, 2024 $63.52M
Revenue FY 2025 · Dec 31, 2023 $377.71M